These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1787992)

  • 1. [Effect of dimephosphon on the clinico-immunological indicators in children with chronic hepatitis].
    Gorbunova IV; Shabunina EI; Maianskaia IV; Studentsova IA
    Pediatriia; 1991; (10):111-2. PubMed ID: 1787992
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B].
    Idrisova RS; Tsoĭ IG
    Pediatriia; 1984 Aug; (8):16-8. PubMed ID: 6333670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].
    Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A; Cianciara J; Loch T; Babiuch L
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):347-51. PubMed ID: 1700402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications for using thymalin in the therapy of children with chronic viral hepatitis B].
    Gol'zand IV; Goriacheva LG; Volkov VO; Khavinson VKh; Morozov VG
    Voen Med Zh; 1986 Mar; (3):27-8. PubMed ID: 3487166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Markers of chronic hepatitis B in children after completion of therapy with isoprinosine].
    Kowalik-Mikołajewska B; Barszcz T; Ladyzyńska E; Wojnarowski M
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):263-4. PubMed ID: 7694263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic active hepatitis B in children: effects of various methods of treatment].
    Egorov VB; Gol'zand IV
    Pediatriia; 1991; (2):52-6. PubMed ID: 2057294
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunogenetic indicators in protracted hepatitis and their dynamics during the treatment with T-activin].
    Stanevicha VA; Veksler KhM
    Pediatriia; 1991; (10):44-8. PubMed ID: 1787998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The microhemodynamics and immune status of patients with chronic viral lesions of the liver and their correction].
    Frolov VM; Petrunia AM; Pinskiĭ LL
    Lik Sprava; 1996; (10-12):144-6. PubMed ID: 9138793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunoenhancing effect of cianidanol (C) on macrophages and on the T-cell system.
    Rauch G
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):147-50. PubMed ID: 3487015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of secondary immunologic deficiency in children with chronic hepatitis B and the methods of its correction].
    Gol'zand IV; Egorov VB; Popova IA
    Ter Arkh; 1989; 61(2):72-6. PubMed ID: 2786265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulator therapy in chronic viral hepatitis].
    Stanciu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):491-502. PubMed ID: 2484221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characteristics of chronic hepatitis B in children and the principles of its staged treatment].
    Gol'zand IV; Murav'eva NN; Goriacheva LG; Bulovskaia LN; Gorvat NA
    Pediatriia; 1987; (3):40-4. PubMed ID: 3601536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the cellular reactions in children with chronic hepatitis B, and the use of immunoregulatory drugs].
    Gol'zand IV; Goriacheva IG; Volkov VO; Romantsov MG; Khavinson VG
    Pediatriia; 1984 Aug; (8):12-5. PubMed ID: 6333669
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of interferon on activated peripheral blood T lymphocytes in patients with chronic active hepatitis B.
    Raptopoulou-Gigi M; Orphanou-Koumerkeridou H
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):577-88. PubMed ID: 7876462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory T subsets in chronic active viral hepatitis: characterization by monoclonal antibodies.
    Pignata C; Vajro P; Troncone R; Monaco G; Ciriaco M
    J Pediatr Gastroenterol Nutr; 1983 May; 2(2):229-33. PubMed ID: 6223993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinico-immunological efficacy of the new drug preparation Erbisol in patients with chronic hepatitis].
    Bychkova NG; Shipulin VP; Fomina AA; Bychkova SA
    Lik Sprava; 1995; (3-4):65-7. PubMed ID: 8819925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of immunological indices in patients with chronic viral hepatitis B and the effect of thymalin therapy].
    Gol'zand IV; Murav'eva NN; Goriacheva LG
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):38-41. PubMed ID: 2945347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic response of chronic active hepatitis B (CAHB) to a new immunomodulator: AM3. Immunohematological effects.
    Villarrubia VG; Valladolid JM; Elorza FL; Sada G; Vilchez JG; Jimenez M; Herrerias JM
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):141-64. PubMed ID: 1597653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of dimephosphon on the immune status of children with pyelonephritis].
    Zernov IN; Volodina NV
    Pediatriia; 1988; (5):23-5. PubMed ID: 3174333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.